Featured Research

from universities, journals, and other organizations

University of Florida Researchers Report Nerve Tissue Transplant Recipient Is Stable

Date:
October 27, 1997
Source:
University of Florida
Summary:
University of Florida researchers, the nation's first to perform an experimental nerve tissue transplant to slow the progression of spinal cord damage in humans, report the condition of a 43-year-old North Florida man has not worsened since the procedure.

By Melanie Fridl Ross

GAINESVILLE, Fla.---University of Florida researchers, the nation's first to perform an experimental nerve tissue transplant to slow the progression of spinal cord damage in humans, report the condition of a 43-year-old North Florida man has not worsened since the procedure.

The man received the transplant July 11 at Shands at UF.

UF physicians announced the results Saturday (10/25) at the National Neurotrauma Symposium, held in New Orleans in conjunction with the annual Society for Neuroscience meeting. Last Wednesday (10/22), they discharged a second patient, a 50-year-old Central Florida man paralyzed after a motorcycle accident. The man, who underwent the procedure Oct. 10, will continue to recuperate in a rehabilitation hospital.

The experimental treatment involved injecting small pieces of human embryonic spinal cord cells directly into an expanding cavity -- also known as a cyst -- that sometimes forms at the site of a specific type of spinal cord injury. The condition can cause unbearable pain and progressive loss of sensation and movement.

UF neurosurgeon Richard Fessler and his colleagues at the UF Brain Institute performed the procedures to test the safety and feasibility of the grafts, which in landmark laboratory studies have helped injured cats regain some use of their paralyzed limbs. Researchers say the test is an important first step in developing a future treatment that can restore at least partial use of limbs or organs left paralyzed by a crushing spinal cord injury.

"This is very early in our evaluation stage," said Fessler, who performed the transplants. "Our first patient's cyst was very complicated; it was walled off into many small compartments. The areas in which we did not transplant look the same, but the areas in which we did transplant, the cyst did not recur, so we're very encouraged by that."

Magnetic resonance imaging scans show that so far the cavity has not reopened or refilled with fluid in the regions where the tissue transplant was placed, said Dr. Ed Wirth, a research assistant professor in UF's department of neuroscience.

"Even so, we feel it will take at least six months to a year to say for certain whether the transplant has successfully prevented the cavity from refilling and re-expanding," he said.

The second patient's surgery was uneventful, Fessler said.

"He's recovered very rapidly and is doing very well," he said.

Eight more paralyzed volunteers will undergo the procedure as part of a four-year pilot study at UF. The transplant recipients' identities were not disclosed to protect their privacy.

Only patients who have a chronic disorder called syringomyelia, characterized by expansion of a fluid-containing cavity within the damaged spinal cord, are considered for the transplant.

Study participants receive the tissue grafts while undergoing standard surgery, which exposes the spinal cord and drains the fluid-filled cavity through a tube. The spinal shunts, or tubes, often do not permanently halt the cavity's expansion and many patients undergo the treatment repeatedly.

The tissue was obtained from aborted tissue, 6 to 9 weeks old, which otherwise would have been discarded. Researchers said they used such tissue because of its exceptional ability to grow and fill lesion cavities, and because it develops into all of the cell types normally seen in the adult spinal cord. The tissue was obtained from health-care facilities not affiliated with the university.

Doctors will continue to assess the patients' progress every few months, using a battery of tests to rate motor function and sensation, the ability of the spinal cord to transmit information, and level of pain.

-----------------------------------------

Recent UF Health Science Center news releases also are available on the UF Health Science Center Communications home page. Point your browser to http://www.vpha.health.ufl.edu/hscc/index.html

For the UF Health Science Center topic/expert list, point your browser to http://www.health.ufl.edu/hscc/experts.html


Story Source:

The above story is based on materials provided by University of Florida. Note: Materials may be edited for content and length.


Cite This Page:

University of Florida. "University of Florida Researchers Report Nerve Tissue Transplant Recipient Is Stable." ScienceDaily. ScienceDaily, 27 October 1997. <www.sciencedaily.com/releases/1997/10/971027094940.htm>.
University of Florida. (1997, October 27). University of Florida Researchers Report Nerve Tissue Transplant Recipient Is Stable. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/1997/10/971027094940.htm
University of Florida. "University of Florida Researchers Report Nerve Tissue Transplant Recipient Is Stable." ScienceDaily. www.sciencedaily.com/releases/1997/10/971027094940.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins